glp-1 weight loss program near me Vibrance By Hometown New year… new goals and

How to Decrease GLP-1 Side Effects Through Diet

The SELECT trial , published in the New England Journal of Medicine and conducted across 804 sites in 41 countries with 17,604 participants, showed semaglutide reduced major adverse cardiovascular events by 20% in people with obesity but without diabetes

Nutrition, Metabolism and Cardiovascular Diseases , 33(8), 1570-1579

doi:10.1056/NEJMoa2307563 Jastreboff AM, Kaplan LM, Frias JP, et al

The 2026 EASO pharmacotherapy update explicitly ranks tirzepatide above semaglutide for weight loss, while supporting semaglutide as the better-documented option for liver fibrosis endpoints in MASH [1]

Allulose stands out because it tastes like sugar, but metabolically behaves very differently, says one of the papers authors, Benjamin Bikman, Ph.D., a metabolic health researcher and professor at Brigham Young University